PHAT SCHEDULE 13G/A: SEC filing
Invesco Ltd.
Filed with the SEC on · accession 0000914208-26-000448
PHAT filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 10, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.2% by the first close after the filing.
Summary of the filing
Invesco Ltd. filed an amended Schedule 13G indicating it beneficially owns 30,562 shares of Phathom Pharmaceuticals, representing 0.0% of the class, a passive investment position.
Key details
How PHAT stock reacted
Close before
$5.33
Nov 9, 2026
First close after
+2.16%
$5.45
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for PHAT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PHAT?
Click hereFrequently asked questions
What did PHAT file with the SEC on Nov 10, 2026?
PHAT filed a SCHEDULE 13G/A (SEC filing). Invesco Ltd. filed an amended Schedule 13G indicating it beneficially owns 30,562 shares of Phathom Pharmaceuticals, representing 0.0% of the class, a passive investment position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did PHAT stock react to this filing?
PHAT closed at $5.33 before the filing and $5.45 on Nov 10, 2026 (+2.16%).
Other PHAT SEC filings
- SCHEDULE 13D/A · SEC filingNov 2, 2026
- 10-Q · SEC filingOct 29, 2026
- 8-K · SEC filingOct 29, 2026
- 8-K · Regulatory actionOct 26, 2026
- 8-K · Regulatory actionOct 23, 2026
- 8-K · Fda approvalSep 29, 2026
- 8-K · SEC filingJul 30, 2026
- 10-Q · SEC filingJul 30, 2026
- 8-K · Fda approvalJun 23, 2026
- 8-K · Board changeMay 21, 2026
Get alerts when PHAT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days